Centre hospitalier Lyon Sud Hematologie

Pierre-Bénite cedex 69495

0 studies enrolling now · 2 studies all time

What they study most

Myelodysplastic Syndromes

Studies at this site

• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes — Completed
• Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes — Completed